Cargando…

The Diagnostic and Prognostic Roles of Combined Expression of Novel Biomarkers in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma: An Immunohistochemical Study

BACKGROUND & OBJECTIVE: Diagnosis and discrimination of lung adenocarcinoma (LUAD) from lung squamous cell carcinoma (LUSC) is critical to select the appropriate treatment regimen as recently targeted therapies require accurate subtyping of nonsmall-cell lung carcinoma (NSCLCs). There are curren...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alabiad, Mohamed Ali, Harb, Ola A., Abozaid, Mohamed, Embaby, Ahmed, Mandour, Doaa, Hemeda, Rehab, Shalaby, Amany Mohamed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iranian Society of Pathology 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085294/ https://www.ncbi.nlm.nih.gov/pubmed/33936227 http://dx.doi.org/10.30699/IJP.2020.130944.2452

Ejemplares similares

Protein Expression of NEK2, JMJD4, and REST in Clear Cell Renal Cell Carcinoma (ccRCC): Clinical, Pathological, and Prognostic Findings
por: Elsayed, Walid S H, et al.
Publicado: (2023)

Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer
por: Elsayed, Dalia Hamouda, et al.
Publicado: (2023)

Prognostic implication of transforming growth factor alpha in adenocarcinoma of the lung--an immunohistochemical study.
por: Tateishi, M., et al.
Publicado: (1991)

Lung adenocarcinoma and squamous cell carcinoma difficult for immunohistochemical diagnosis can be distinguished by lipid profile
por: Yamashita, Takashi, et al.
Publicado: (2023)

An evaluation of the prognostic significance of alpha-1-antitrypsin expression in adenocarcinomas of the lung: an immunohistochemical analysis.
por: Higashiyama, M., et al.
Publicado: (1992)

Weighted gene expression profiles identify diagnostic and prognostic genes for lung adenocarcinoma and squamous cell carcinoma
por: Wu, Xing, et al.
Publicado: (2019)

Prognostic and diagnostic significance of Cavin 2 in lung adenocarcinoma
por: Wang, Xianguo, et al.
Publicado: (2019)

Diagnostic and prognostic value of the BEX family in lung adenocarcinoma
por: Zhang, Zhong-Hao, et al.
Publicado: (2019)

Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma
por: Li, Jingyuan, et al.
Publicado: (2020)

CLCA2 as a Novel Immunohistochemical Marker for Differential Diagnosis of Squamous Cell Carcinoma from Adenocarcinoma of the Lung
por: Shinmura, Kazuya, et al.
Publicado: (2014)

Development of an autophagy-related gene prognostic signature in lung adenocarcinoma and lung squamous cell carcinoma
por: Zhu, Jie, et al.
Publicado: (2020)

Autophagy characteristics and establishment of autophagy prognostic models in lung adenocarcinoma and lung squamous cell carcinoma
por: Chen, Zhubei, et al.
Publicado: (2022)

Carboxypeptidase N2 as a Novel Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma
por: Xu, Ting, et al.
Publicado: (2022)

Identification and in vitro validation of diagnostic and prognostic biomarkers for lung squamous cell carcinoma
por: Zhao, Xiaopeng, et al.
Publicado: (2022)

Diagnostic and prognostic potential of the oral and gut microbiome for lung adenocarcinoma
por: Lim, Mi Young, et al.
Publicado: (2021)

Prognostic value of immune-related genes in the tumor microenvironment of lung adenocarcinoma and lung squamous cell carcinoma
por: Qu, Yan, et al.
Publicado: (2020)

Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung
por: Brcic, Luka, et al.
Publicado: (2018)

The clinical and prognostic value of polo-like kinase 1 in lung squamous cell carcinoma patients: immunohistochemical analysis
por: Li, Hefei, et al.
Publicado: (2017)

Immunohistochemical markers to diagnose primary squamous cell carcinoma of the lung: a meta-analysis of diagnostic test accuracy
por: Chen, Hao, et al.
Publicado: (2022)

Antimicrobial Activity of Silver-Treated Bacteria against Other Multi-Drug Resistant Pathogens in Their Environment
por: Mohamed, Doaa Safwat, et al.
Publicado: (2020)

Maspin Expression in Epithelial Skin Tumours: An Immunohistochemical Study
por: Abdou, Asmaa Gaber, et al.
Publicado: (2011)

The Role of Upregulated DDX11 as A Potential Prognostic and Diagnostic Biomarker in Lung Adenocarcinoma
por: Li, Jianhao, et al.
Publicado: (2019)

Overexpression of hsa_circ_0001715 is a Potential Diagnostic and Prognostic Biomarker in Lung Adenocarcinoma
por: Lu, Guo-jun, et al.
Publicado: (2020)

DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma
por: Wu, Yang-Jie, et al.
Publicado: (2021)

Effect of rolipram, a phosphodiesterase enzyme type–4 inhibitor, on γ-amino butyric acid content of the frontal cortex in mice exposed to chronic mild stress
por: Shalaby, Amany Mohamed, et al.
Publicado: (2012)

Schlafen 12 Is Prognostically Favorable and Reduces C-Myc and Proliferation in Lung Adenocarcinoma but Not in Lung Squamous Cell Carcinoma
por: Al-Marsoummi, Sarmad, et al.
Publicado: (2020)

Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
por: Li, Na, et al.
Publicado: (2021)

Real-World Diagnostic Accuracy and Use of Immunohistochemical Markers in Lung Cancer Diagnostics
por: Ericson Lindquist, Kajsa, et al.
Publicado: (2021)

Prognostic Role of Tumor Microenvironment in DLBCL and Relation to Patients' Clinical Outcome: A Clinical and Immunohistochemical Study
por: Ghorab, Doaa Shams-Deen, et al.
Publicado: (2022)

Aspergilloma in combination with adenocarcinoma of the lung
por: Smahi, Mohamed, et al.
Publicado: (2011)

Therapeutic potential of chrysin nanoparticle-mediation inhibition of succinate dehydrogenase and ubiquinone oxidoreductase in pancreatic and lung adenocarcinoma
por: Ragab, Eman M., et al.
Publicado: (2022)

Accurate and Economical Detection of ALK Positive Lung Adenocarcinoma with Semiquantitative Immunohistochemical Screening
por: Zhou, Jianya, et al.
Publicado: (2014)

Prognostic and clinicopathological values of tissue expression of MFAP5 and ITM2A in triple-negative breast cancer: an immunohistochemical study
por: Abuderman, Abdulwahab A., et al.
Publicado: (2020)

Glypican-1 is a novel immunohistochemical marker to differentiate poorly differentiated squamous cell carcinoma from solid predominant adenocarcinoma of the lung
por: Kai, Yuichiro, et al.
Publicado: (2021)

LINC02126 is a potential diagnostic, prognostic and immunotherapeutic target for lung adenocarcinoma
por: Wang, Junbin, et al.
Publicado: (2022)

Unique genomic features and prognostic value of COSMIC mutational signature 4 in lung adenocarcinoma and lung squamous cell carcinoma
por: Cai, Xiuyu, et al.
Publicado: (2020)

Correlation of PD-L1 immunohistochemical expression with microsatellite instability and p53 status in endometrial carcinoma
por: Arafa, Mohammad, et al.
Publicado: (2022)

MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung
por: Mawas, Amany Sayed, et al.
Publicado: (2018)

LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma
por: Liu, Bing, et al.
Publicado: (2016)

Identification of TLRs as potential prognostic biomarkers for lung adenocarcinoma
por: Ying, Junjie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lnb0jb13j6udh22c61vrb5vcts